跳到正文
收录说明
收录范围
保留计量方法研究、相关统计基础,以及实质涉及计量方法的应用、教程、比较和综述。书评、刊务及明确无关内容不公开;身份或相关性证据不足的记录保留待核,补充可靠材料后可重新判断。
预印本来自 arXiv 计量经济学及相关统计、金融分类和主题检索。主题检索从 2021 年起回补;关注作者追溯更早年份,部分历史文献按已核验编号补录。收录不表示通过同行评审,仍可能遗漏。
本库首次提交范围:2004-06-23 — 2026-10-14。
阅读范围
默认显示本库全部预印本。可选“优先阅读”:至少一位作者同时满足有可核验的本站覆盖期刊正式发表记录,且 OpenAlex 总引用超过 1,000 次。按同一作者身份匹配,两项缺一不可。此筛选提供阅读线索,不作为论文质量判断。
日期与排序
默认按最近修订排序;年份和日期筛选使用首次提交时间。同一 arXiv 编号的修订会合并。仅有月份或年份时,日期区间相交也会纳入。

日期精度:到日 6 篇 · 到月 0 篇 · 到年 0 篇

分类与引用
领域和方法依据题名、摘要初步分类,可人工修正;分类不代表论文质量。引用数采用 OpenAlex 单条关联记录,不合计版本。
更新与 AI 解读
正常题录、可靠摘要与引用同步继续;日、周、月简报按核实的发表与修订日期汇总,历史补录保留在文献库。AI 解读依据可靠摘要或已核实原文片段,已有解读保留供阅读参考;缺少可靠材料的条目保持待解读,浏览页面不会触发生成。
6 篇论文
导出

A CV-TMLE global test approach to improve power in rare disease clinical studies with multiple-component endpoints

利用 CV-TMLE 全局检验提高罕见病多组分终点研究的功效

Rare disease trials face unique statistical challenges due to limited patient populations and heterogeneous clinical manifestations among patients. Multiple endpoints are often necessary to comprehensively capture treatment benefits. A global test is an approach for evaluating whether a treatment has any beneficial effect across multiple endpoints. We propose a new global test based on a weighted composite endpoint. The proposed global test employs shrinkage-based…

AI 解读阅读原文 ↗BibTeX ↓

Investigating Targeting Strategies and Truncation in TMLE for the Average Treatment Effect under Practical Positivity Violations

实际正值性违背下平均处理效应 TMLE 的目标化策略与截断研究

Estimating average treatment effects from observational data is challenging under practical violations of the positivity assumption. Targeted Maximum Likelihood Estimators (TMLEs) are widely used because of their double robustness and efficiency, but they can remain sensitive to such violations. We conduct extensive simulation studies to examine how targeting strategies and truncation levels affect TMLE performance under varying degrees of outcome regression misspecification…

AI 解读阅读原文 ↗BibTeX ↓

Assessing treatment effects in observational data with missing confounders: A comparative study of practical doubly-robust and traditional missing data methods

混杂变量缺失时的处理效应评估:双重稳健与传统缺失数据方法比较

In pharmacoepidemiology, safety and effectiveness are frequently evaluated using readily available administrative and electronic health records data. In these settings, detailed confounder data are often not available in all data sources and therefore missing on a subset of individuals. Multiple imputation (MI) and inverse-probability weighting (IPW) are go-to analytical methods to handle missing data and are dominant in the biomedical literature. Doubly-robust methods,…

AI 解读阅读原文 ↗BibTeX ↓

A cautionary note for plasmode simulation studies in the setting of causal inference

因果推断中 Plasmode 模拟研究的注意事项

Plasmode simulation has become an important tool for evaluating the operating characteristics of different statistical methods in complex settings, such as pharmacoepidemiological studies of treatment effectiveness using electronic health records (EHR) data. These studies provide insight into how estimator performance is impacted by challenges including rare events, small sample size, etc., that can indicate which among a set of methods performs best in a real-world dataset.…

AI 解读阅读原文 ↗BibTeX ↓

Technical Note: Targeted Maximum Likelihood Estimator for an ATE Standardized for New Target Population

技术说明:针对新目标总体标准化平均处理效应的靶向最大似然估计

In this technical note we present a targeted maximum likelihood estimator (TMLE) for a previously studied target parameter that aims to transport an average treatment effect (ATE) on a clinical outcome in a source population to what the ATE would have been in another target population. It is assumed that one only observes baseline covariates in the target population, while we assume that one can learn the conditional treatment effect on the outcome of interest in the source…

AI 解读阅读原文 ↗BibTeX ↓

An Application of the Causal Roadmap in Two Safety Monitoring Case Studies: Covariate-Adjustment and Outcome Prediction using Electronic Health Record Data

因果路线图在两项安全监测案例中的应用:电子病历协变量调整与结局预测

Real-world data, such as administrative claims and electronic health records, are increasingly used for safety monitoring and to help guide regulatory decision-making. In these settings, it is important to document analytic decisions transparently and objectively to ensure that analyses meet their intended goals. The Causal Roadmap is an established framework that can guide and document analytic decisions through each step of the analytic pipeline, which will help…

AI 解读阅读原文 ↗BibTeX ↓